BIOMAT Database Logo BIOMAT Database Logo

Frequent loss of heterozygosity on chromosome 6p in uveal melanoma. 1999

J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Department of Ophthalmology, Leiden University Medical Center, The Netherlands. JMetzelaar@div3.azl.nl

Lack of expression of HLA class I antigens is frequently observed on primary uveal melanoma, and is correlated with improved patient survival. Several mechanisms may contribute to the observed loss of HLA class I expression, including changes at the DNA level. In this study, we used microsatellite analysis as a molecular genetic approach to examine loci on chromosome 6p for loss of heterozygosity (LOH). Three pairs of microsatellite markers were used to screen 20 formalin-fixed, paraffin-embedded uveal melanomas for LOH on the short arm of chromosome 6. In all cases, normal adjacent scleral tissue was used as a control. We identified LOH in eleven cases from microsatellite locus D6S105 to the telomere, in eight cases from microsatellite locus D6STNFa to the telomere (area includes D6S105), and in seven cases from microsatellite locus D6S291 to the end of chromosome 6p (includes D6STNFa and D6S105). In seven cases, retention of heterozygosity was found at all three loci using these primers. Our results suggest that loss of heterozygosity on chromosome 6p is a common feature in uveal melanoma. We did not find a correlation between the presence of LOH and locus-specific HLA-A and -B expression.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D002830 Choroid Neoplasms Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi). Choroidal Neoplasms,Choroid Neoplasm,Choroidal Neoplasm,Neoplasm, Choroid,Neoplasm, Choroidal,Neoplasms, Choroid,Neoplasms, Choroidal
D002896 Chromosomes, Human, Pair 6 A specific pair GROUP C CHROMSOMES of the human chromosome classification. Chromosome 6
D002924 Ciliary Body A ring of tissue extending from the scleral spur to the ora serrata of the RETINA. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion. Corpus Ciliare,Corpus Ciliaris,Bodies, Ciliary,Body, Ciliary,Ciliare, Corpus,Ciliares, Corpus,Ciliari, Corpus,Ciliaris, Corpus,Ciliary Bodies,Corpus Ciliares,Corpus Ciliari
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014604 Uveal Neoplasms Tumors or cancer of the UVEA. Neoplasm, Uveal,Neoplasms, Uveal,Uveal Neoplasm
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015235 HLA-B Antigens Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Antigens, HLA-B,HLA-B Antigen,HLA-B,Antigen, HLA-B,Antigens, HLA B,HLA B Antigen,HLA B Antigens
D015353 Eye Enucleation The surgical removal of the eyeball leaving the eye muscles and remaining orbital contents intact. Enucleation Surgery,Enucleation Technique,Enucleation Surgeries,Enucleation Techniques,Enucleation, Eye,Eye Enucleations,Surgery, Enucleation
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity targeting the inactive X chromosome in melanoma.
December 2003, Clinical cancer research : an official journal of the American Association for Cancer Research,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
March 1989, Cancer research,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
May 1993, Hepatology (Baltimore, Md.),
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
March 1993, British journal of cancer,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
[Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
January 2001, Zhonghua yi xue za zhi,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.
March 1993, Oncogene,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas.
June 1996, Genes, chromosomes & cancer,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.
May 2011, Virchows Archiv : an international journal of pathology,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
May 1995, British journal of cancer,
J A Metzelaar-Blok, and M J Jager, and P H Moghaddam, and A R van der Slik, and M J Giphart
Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.
August 2000, Molecular pathology : MP,
Copied contents to your clipboard!